Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by jdunlopon Jun 23, 2024 8:59pm
141 Views
Post# 36102624

RE:RE:RE:RE:RE:DEAD

RE:RE:RE:RE:RE:DEAD

Tks. for the info. 

 


SQI Diagnostics downgraded to NEX

 

2024-02-15 18:32 ET - Symbol Change

 

In accordance with TSX Venture Exchange Policy 2.5, the company has not maintained the requirements for a TSX Venture Exchange Tier 2 company. Therefore, effective at the opening on Tuesday, Feb. 20, 2024, the company's listing will transfer to the NEX, the company's tier classification will change from Tier 2 to the NEX, and the filing and service office will change from Toronto to the NEX.

As of Feb. 20, 2024, the company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies.

The trading symbol for the company will change from SQD to SQD.H. There is no change in the company's name, no change in its Cusip number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture Exchange market.

Further to the TSX Venture Exchange bulletin dated Sept. 6, 2023, trading in the shares of the company will remain suspended.

Members are prohibited from trading in the securities of the company during the period of the suspension or until further notice.

© 2024 Canjex Publishing Ltd. All rights reserved.

<< Previous
Bullboard Posts
Next >>